Published: 13 sept. 2024(Updated: 25 nov. 2024)
•26 min
•26 min read
•Larissa Brosi, Thomas K. Villiger, Frank I. Bantleon, Anna Melone, Marie-Eve Überschlag, Daniele Dolce, Cedric Giegelmann, Michael Gerspach, Lorin Dirscherl, Sherin Panikulam, Patrick Romann +Development of a unique rapid test to detect antibodies directed against an extended RBD of SARS-CoV-2 spike protein
Cell culture
Researchers at University of Applied Sciences and Arts Northwestern Switzerland FHNW worked to develop a rapid test that measures patient immune protection from SARS-CoV-2, resulting from prior infection or vaccination. Their work utilized INFORS HT's Techfors-S pilot bioreactor.